These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24950702)

  • 41. Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas.
    Ohike N; Coban I; Kim GE; Basturk O; Tajiri T; Krasinskas A; Bandyopadhyay S; Morohoshi T; Shimada Y; Kooby DA; Staley CA; Goodman M; Adsay NV
    Am J Surg Pathol; 2010 Oct; 34(10):1417-24. PubMed ID: 20871215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential features of pancreatobiliary- and intestinal-type ampullary carcinomas at MR imaging.
    Chung YE; Kim MJ; Park MS; Choi JY; Kim H; Kim SK; Lee M; Kim HJ; Choi JS; Song SY; Kim KW
    Radiology; 2010 Nov; 257(2):384-93. PubMed ID: 20829529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
    Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC
    Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Whipple's operation for carcinoma of the pancreatic head and the ampullary region. Short-and long-term results.
    Sørensen MB; Lundemose JB; Rokkjaer M; Jacobsen NO
    Scand J Gastroenterol; 1998 Jul; 33(7):759-64. PubMed ID: 9712242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
    Kwon MJ; Kim JW; Jung JP; Cho JW; Nam ES; Cho SJ; Kim JS; Park HR; Min SK; Seo J; Min KW; Kim DH; Jeon JY
    Hum Pathol; 2016 Apr; 50():90-100. PubMed ID: 26997442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
    Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
    J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Revisiting the concept of lymph node metastases of pancreatic head cancer: number of metastatic lymph nodes and lymph node ratio according to N stage.
    Kang MJ; Jang JY; Chang YR; Kwon W; Jung W; Kim SW
    Ann Surg Oncol; 2014 May; 21(5):1545-51. PubMed ID: 24419758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
    Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
    J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survival advantage with para aortic lymphadenectomy in peri-ampullary cancer: A retrospective cohort study.
    Hafeez Bhatti AB; Dar FS; Sahaab E; Khan NY; Zia H; Rana A; Salih M; Shah NH
    Int J Surg; 2016 Jul; 31():58-62. PubMed ID: 27262530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.
    Zenali M; Overman MJ; Rashid A; Broaddus RB; Wang H; Katz MH; Fleming JB; Abbruzzese JL; Wang H
    Hum Pathol; 2013 Dec; 44(12):2792-8. PubMed ID: 24139211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases.
    McCarthy DM; Hruban RH; Argani P; Howe JR; Conlon KC; Brennan MF; Zahurak M; Wilentz RE; Cameron JL; Yeo CJ; Kern SE; Klimstra DS
    Mod Pathol; 2003 Mar; 16(3):272-8. PubMed ID: 12640108
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA aneuploidy is an independent factor of poor prognosis in pancreatic and peripancreatic cancer.
    Sciallero S; Giaretti W; Geido E; Bonelli L; Zhankui L; Saccomanno S; Zeraschi E; Pugliese V
    Int J Pancreatol; 1993 Aug; 14(1):21-8. PubMed ID: 8409573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: Depth of invasion matters.
    Addeo P; Velten M; Averous G; Faitot F; Nguimpi-Tambou M; Nappo G; Felli E; Fuchshuber P; Bachellier P
    Surgery; 2017 Aug; 162(2):264-274. PubMed ID: 28576385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced expression of p21-activated protein kinase 1 correlates with poor histological differentiation in pancreatic cancer.
    Han J; Wang F; Yuan SQ; Guo Y; Zeng ZL; Li LR; Yang J; Wang DS; Liu MY; Zhao H; Liu KY; Liao JW; Zou QF; Xu RH
    BMC Cancer; 2014 Sep; 14():650. PubMed ID: 25182632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HHLA2 is expressed in pancreatic and ampullary cancers and increased expression is associated with better post-surgical prognosis.
    Boor PPC; Sideras K; Biermann K; Hosein Aziz M; Levink IJM; Mancham S; Erler NS; Tang X; van Eijck CH; Bruno MJ; Sprengers D; Zang X; Kwekkeboom J
    Br J Cancer; 2020 Apr; 122(8):1211-1218. PubMed ID: 32071413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers.
    Kwon MJ; Kim JW; Jeon JY; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Min KW; Choe JY; Lee HK
    Pathol Res Pract; 2017 Apr; 213(4):381-388. PubMed ID: 28214200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival estimates after pancreatoduodenectomy skewed by non-standardized histopathology reports.
    Westgaard A; Clausen OP; Gladhaug IP
    APMIS; 2011 Oct; 119(10):689-700. PubMed ID: 21917006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
    Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
    Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].
    Soriano-Izquierdo A; Adet AC; Gallego R; Miquel R; Castells A; Pellisé M; Nadal C; López-Boado MA; Piqué JM; Gascón P; Conill C; Bombí A; Fernández-Cruz L; Maurel J; Navarro S
    Med Clin (Barc); 2009 Feb; 132(5):163-71. PubMed ID: 19211081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.